S015 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
1:00 PM
Introduction
Kishwer S. Nehal, MD, FAAD
1:00 PM
Nail Surgery Tips
Elizabeth M. Billingsley, MD, FAAD
1:16 PM
Photography/Biopsy Site Identification
Cristian Navarrete-Dechent, MD, IFAAD
1:32 PM
Surgical Instruments
Kishan Mitesh Shah, MD, FAAD
1:48 PM
Q&A
2:00 PM
Technology tools for 2026
David R. Carr, MD, MPH, FAAD
2:16 PM
Communicating with your Dermatopathologist
Valencia D. Thomas, MD, FAAD
2:32 PM
Tips for your Practice
Ramin Fathi, MD, FAAD
2:48 PM
Q&A
3:00 PM
Wellness and Combatting Burnout
Emily Clara Newsom, MD, FAAD
3:16 PM
Attention to Safety / Reducing Risk
Rachel Rigo, MD, FAAD
3:32 PM
Ergonomic Strategies for your Practice
Patrick K. Lee, MD, FAAD
3:48 PM
Q&A
DIRECTOR
Kishwer S. Nehal, MD, FAAD
SPEAKERS
Elizabeth M. Billingsley, MD, FAAD
David R. Carr, MD, MPH, FAAD
Ramin Fathi, MD, FAAD
Patrick K. Lee, MD, FAAD
Cristian Navarrete-Dechent, MD, IFAAD
Emily Clara Newsom, MD, FAAD
Rachel Rigo, MD, FAAD
Kishan Mitesh Shah, MD, FAAD
Valencia D. Thomas, MD, FAAD
DISCLOSURES
Elizabeth M. Billingsley, MD, FAAD
Inhibitor Therapeutics – Consultant (1099 relationship)(Fees); PellePharm, Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sol Gel Technologies – Investigator(Grants/Research Funding);
David R. Carr, MD, MPH, FAAD
Regeneron – Investigator(No Compensation Received);
Ramin Fathi, MD, FAAD
No financial relationships exist with ineligible companies.
Patrick K. Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Cristian Navarrete-Dechent, MD, IFAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Emily Clara Newsom, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Kishan Mitesh Shah, MD, FAAD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);